Most Read Stories
Abiraterone or Enzalutamide for Newly Diagnosed Metastatic Castrate-Resistant Prostate Cancer?
Study Identifies Specific Genes Associated With Increased Risk for Triple-Negative Breast Cancer
Sunitinib vs Nephrectomy Followed by Sunitinib in Metastatic Renal Cell Carcinoma
Osimertinib Resistance Mechanisms in EGFR T790M–Positive NSCLC
Long-Term Pooled Safety Data for Palbociclib Combined With Endocrine Therapy in HR-Positive, HER2-Negative Breast Cancer
FDA Approves Mogamulizumab-kpkc for Two Rare Types of Non-Hodgkin Lymphoma
Utilization of Hypofractionated Radiation Therapy in Breast Cancer
Enzalutamide Prolongs Metastasis-Free Survival in Patients With Nonmetastatic, Castration-Resistant Prostate Cancer
Meeting the Challenges of Immunotherapy-Related Toxicities
High False-Positive Rate of Elevated CEA Seen in Patients With Resected Colorectal Cancer
Why Oncologists Should Decline to Participate in the Right to Try Act
CNS Activity of EGFR Tyrosine Kinase Inhibitor in T790M-Positive Advanced NSCLC
No Benefit of Adding Abiraterone to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Increasing PSA
Guidelines for Pediatric CAR T-Cell Therapy Developed
A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?
New Frontiers Being Explored in Multiple Myeloma
Apatinib and Oral Etoposide in Platinum-Resistant/Refractory Ovarian Cancer
Lung Cancer Screening Guidelines May Be Inadequate for High-Risk Minorities
Response to Ibrutinib in Symptomatic Untreated Waldenström’s Macroglobulinemia
CAR T-Cell Therapy in Lymphoma: Challenges Come With Success

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.